These findings suggest that NAb could be used to select for animals that are less prone to clinical mastitis, in agreement with the results of Thompson-Crispi et al. [18] for KLH-IgM and of Ploegaert et al. [62] for IgM and IgA NAb. Here, CD79A is linked to mastitis.